SCHEMBL7691063

SCHEMBL7691063

CC(C)(C)c1cc(Nc2nc3cc4ccccc4cc3nc2NCCCn2ccnc2)n(-c2ccccc2)n1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SOD1 P00441 3/20 0.50
ALDH1A1 P00352 6/20 0.49
KDM4E B2RXH2 4/20 0.49
MAPT P10636 4/20 0.49
RAB9A P51151 4/20 0.49
MAPK1 P28482 3/20 0.49
NPSR1 Q6W5P4 2/20 0.49
NPC1 O15118 2/20 0.49
GSK3A P49840 1/20 0.44
GSK3B P49841 1/20 0.44
HPGD P15428 3/20 0.42
LMNA P02545 2/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
HTT P42858 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
MAPK14 Q16539 3/20 0.42
MAPK12 P53778 2/20 0.42
MAPK13 O15264 1/20 0.42
MAPK11 Q15759 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7692769 0.93 KDM4E (0.49) SOD1ALDH1A1KDM4EMAPTRAB9A
SCHEMBL7695893 0.92 SOD1 (0.46) SOD1ALDH1A1KDM4EMAPTRAB9A
SCHEMBL7700746 0.84 JAK2 (0.48) LMNAMAPK14MAPK12MAPK13MAPK11
SCHEMBL7694581 0.80 SOD1 (0.74) SOD1ALDH1A1KDM4EMAPTRAB9A
SCHEMBL7691825 0.80 JAK2 (0.46) MAPTMAPK1NPSR1HPGDLMNA
SCHEMBL7696799 0.77 JAK2 (0.45) MAPTLMNAHTTMAPK14MAPK12
SCHEMBL7697247 0.76 MAPK14 (0.48) ALDH1A1KDM4EMAPTHPGDLMNA
SCHEMBL7692071 0.76 MAPK14 (0.49) GSK3AMAPK14MAPK12MAPK13MAPK11
SCHEMBL7693923 0.76 MAPK14 (0.45) MAPK14MAPK12MAPK13MAPK11JAK2
SCHEMBL7695414 0.75 MAPK13 (0.42) MAPTRAB9AMAPK1NPSR1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002094796-A2 BENZO[G]QUINOXALINE DERIVATIVES AS EFFECTIVE COMPOUNDS AGAINST INFECTIOUS DISEASES AXXIMA PHARMACEUTICALS AG (DE) 2002-11-28 WO disclosed